Doctor Sanjeev Sewak
Publications
Journals
S Sewak, P Graham, J Nankervis. Tattoo allergy in patients receiving adjuvant radiotherapy for breast cancer. Australasian Radiology 1999; 43: 558-561.
S Sewak, FM Muggia, D Zagzag. Endometrial Carcinoma with cerebellar metastasis: A case report illustrating an emerging association? J. Neurooncol 2002; 58(2): 137-140.
E Newman, SG Marcus, M Potmesil, S Sewak, H Yee, J Sorich, M Hayek, F Muggia, H Hochster. Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer. J. Gastrointest Surg 2002, 6(2): 212-223.
S Sewak, A Chachoua, A Hamilton, S Taneja, J Lee, M Utate, J Sorich, FM Muggia. A phase 1 study of paclitaxel, estramustine phosphate and vinorelbine (PaclEVin) in advanced malignancies: Triple tublin targeting. Anticancer Drugs 2003, 14:67-72.
M Haigentz, M Kim, J Sorich, J Lee, H Hochster, M Macapinlac, D Mirchandani, S Sewak A Pavlick, M Volm, A Hamilton, F Muggia. Phase I study of amifostine as a cytoprotector of gemcitabine/cisplatin combination in patients with advanced solid malignancies. Anticancer Drugs, 2003, 14: 321-326.
S Sewak, J Sorich, J O’Leary. A phase I trial of continuous infusion 9-amino-camptothecin in patients with advanced solid tumors. 21-day infusion is an active regimen. Anticancer Drugs, 2006, 17: 571-579.
S Sewak. Highlights from the 2006 Prostate Cancer Symposium. Victorian Cooperative Oncology Group, Urological Cancer Update, 2006, 20: 9-11.
C Yap, C Hair, S Foy, S Sewak, M Francis, J Kenny. Resection of right atrial metastatic large-cell neuroendocrine carcinoma. Asian Cardiovasc Thorac Ann, 2007, 15: 20-22.
S Sewak, S Kosmider, V Ganju, A Woollett, B Le, E Yeow, M Henry, M Debrincat, R Bell. A phase 2 study of Paclitaxel and Vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer (HRPC): Double Tubulin Targeting. Int Med J, 2010, 40(3): 201-208.
A Lomax, Sew Y Yap, K White, J Beith, E Abdi, A Broad, S Sewak, C Lee, P Sambrook, N Pockcock, M Henry, E Yeow, R Bell. Prevention of Aromatase Inhibitor-induced bone loss with Alendronate in postmenopausal women: The Batman Trial. J of Bone Onc (2013), http://dx.doi.org/10.1016/j.jbo.2013.08.001
Oncology beyond science S Sewak - Indian Journal of Medical and Paediatric Oncology, 2020 - ijmpo.org Editorial piece.
B. Josephs, S. Sewak. Two clinical cases of metastatic Merkel cell carcinoma illustrating a major advancement in management. Indian Journal of Medical and Paediatric Oncology, 2021, in-press.
Conference Abstracts
L Liebes, H Hochster, CC Conway, A Chachoua, S Sewak, K Farrell, A Cosmidis, S Mendoza, R Shore, J Crowell, SS Hecht, S Carmella, F Chung. Thirty day multiple dose administration of PEITC: A phase 1 study with steady state pharmacokinetics showing good tolerance through 120mg daily. Proc. Am Assoc Cancer Res 42:834, abstract 4477, 2001.
E Newman, S Marcus, M Potmesil, H Hochster, H Yee, S Sewak, Hayek M, and F Muggia. CPT-11 based neoadjuvant therapy followed by resection and intraperitoneal therapy (IP) for gastric cancer. Proc 4th International Gastric Cancer Congress, Abstract 639, 2001.
S Sewak, A Chachoua, A Hamilton, S Taneja, J Lee, M Utate, J Sorich, L Kutz, J Goldberg, F Muggia. Pacl-E-Vin: Triple tubulin targeting in a phase I study of paclitaxel, estramustine phosphate and vinorelbine. Proc Am Soc Clin Oncol, abstract 2121, 2001.
FM Muggia, M Haigentz, J Lee, A Chachoua, H Hochster, M Meyers, R Oratz, JL Speyer, M Volm, S Sewak, C Wasserheit, JC Wenz, M Kim, J Sorich. Gemcitabine (G)/Cisplatin (P) with and without Amifostine (A): Comparative Toxicities. Proc Am Soc Clin Oncol, abstract 484, 2001.
S Sewak, S Kosmider, V Ganju, A Woollett, B Le, E Yeow, M Henry, R Bell. A phase 2 study of Paclitaxel and Vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer (HRPC): Double tubulin targeting. Proc Am Soc Clin Onc, abstract14559, 2006
S Sewak, S Kosmider, V Ganju, A Woollett, B Le, E Yeow, M Henry, R Bell. A phase 2 study of Paclitaxel and Vinorelbine (Pacl-Vin) in hormone-refractory metastatic prostate cancer (HRPC): A final update. Proc Am Soc Clin Onc, abstract# 32043, 2007
K White, E Yeow, J Beith, C.P. Lee, A Broad, S Sewak, E Abdi, P. N. Sambrook, R Bell. Assessment of an algorithm for prevention of aromatase inhibitor-associated bone loss: Two year results. Euro J of Cancer Supp, Abstract 354, Vol 18(3), March 2010, p161.
A Lomax, Sew Y Yap, K White, J Beith, E Abdi, A Broad, S Sewak, C Lee, P Sambrook, N Pockcock, M Henry, E Yeow, R Bell. Prevention of Aromatase Inhibitor-induced bone loss with Alendronate in postmenopausal women: The Batman Trial. ANZBMS Annual Scientific Meeting 2013, Plenary poster/abstract.
C Sardjono, J Bower, P McLeod, P Mainwaring, S Sewak, et al. A phase 2 study of sequential therapy with Pazopanib followed by Everolimus in metastatic renal cell carcinoma- study update. MOGA Annual Scientific Meeting 2014, poster/abstract.